{"webUser":null,"request_id":"1442a3f11a04bfffaca6e162f67d61e7"}
{"flashNotices":[],"request_id":"1442a3f11a04bfffaca6e162f67d61e7"}

OncLive® On Air / FDA Approval Insights: Ropeginterferon Alfa-2b Ushers in Long-Awaited New Treatment Option for Essential Thrombocythemia

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.